Publication:
The role of methyl prednisolone and intravenous (IV) cyclophosphamide combination treatment in patients with idiopathic membranoproliferative glomerulonephritis (IMPGN)

Simple item page
dc.contributor.authorsKoc, M; Arikan, H; Al Ahdap, Y; Abdalla, O; Eren, Z; Guven, B; Kocak, S; Tuglular, S; Ozener, C; Akoglu, E
dc.date.accessioned2022-03-12T15:59:03Z
dc.date.accessioned2026-01-11T13:16:41Z
dc.date.available2022-03-12T15:59:03Z
dc.date.issued2005
dc.identifier.doidoiWOS:000234376901292
dc.identifier.issn0931-0509
dc.identifier.urihttps://hdl.handle.net/11424/224272
dc.identifier.wosWOS:000234376901292
dc.language.isoeng
dc.publisherOXFORD UNIV PRESS
dc.relation.ispartofNEPHROLOGY DIALYSIS TRANSPLANTATION
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleThe role of methyl prednisolone and intravenous (IV) cyclophosphamide combination treatment in patients with idiopathic membranoproliferative glomerulonephritis (IMPGN)
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageV229
oaire.citation.startPageV229
oaire.citation.titleNEPHROLOGY DIALYSIS TRANSPLANTATION
oaire.citation.volume20

Files

Collections

Araştırma Çıktıları